PRTN3

proteinase 3, the group of Granule associated serine proteases of immune defence

Basic information

Region (hg38): 19:840999-848175

Links

ENSG00000196415NCBI:5657OMIM:177020HGNC:9495Uniprot:P24158AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PRTN3 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PRTN3 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
3
missense
12
clinvar
3
clinvar
1
clinvar
16
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 12 6 1

Variants in PRTN3

This is a list of pathogenic ClinVar variants found in the PRTN3 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
19-841019-G-A Likely benign (Dec 09, 2017)715178
19-841023-C-T Likely benign (Feb 16, 2018)725047
19-843571-G-C not specified Uncertain significance (Oct 25, 2023)3219989
19-843590-G-C not specified Uncertain significance (Oct 27, 2021)2257710
19-843597-G-T Benign/Likely benign (Jan 01, 2024)786842
19-843609-G-T Likely benign (May 18, 2018)717792
19-843973-C-T not specified Uncertain significance (Oct 25, 2023)3219990
19-846150-A-G not specified Uncertain significance (Nov 22, 2023)3219991
19-846169-G-A not specified Likely benign (Jul 06, 2021)2402472
19-846246-T-G not specified Uncertain significance (Jul 08, 2021)2229486
19-846256-T-G not specified Uncertain significance (Sep 17, 2021)2239808
19-846268-A-C not specified Uncertain significance (Jul 06, 2021)2226808
19-846274-C-A not specified Uncertain significance (Jan 02, 2024)3219992
19-846298-A-G not specified Uncertain significance (Mar 31, 2023)2520464
19-846366-G-C not specified Uncertain significance (Jun 07, 2024)3310763
19-847877-C-G not specified Likely benign (May 05, 2023)2544013
19-847878-G-A not specified Uncertain significance (May 28, 2024)3310762
19-847901-C-T not specified Uncertain significance (Feb 17, 2024)3219993
19-847910-C-T not specified Uncertain significance (Jan 08, 2024)3219994
19-847944-G-A Benign (Feb 01, 2024)3024761
19-847957-G-C not specified Uncertain significance (Jan 29, 2024)3219995

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PRTN3protein_codingprotein_codingENST00000234347 57213
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.00003800.3941246630191246820.0000762
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.1531401450.9640.000008451598
Missense in Polyphen3551.6750.67731618
Synonymous-0.6376861.61.100.00000349544
Loss of Function0.23377.700.9094.12e-780

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00009780.0000930
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.0005010.000375
European (Non-Finnish)0.00006060.0000533
Middle Eastern0.000.00
South Asian0.00007050.0000328
Other0.0003570.000329

dbNSFP

Source: dbNSFP

Function
FUNCTION: Serine protease that degrades elastin, fibronectin, laminin, vitronectin, and collagen types I, III, and IV (in vitro) (PubMed:3198760, PubMed:2033050, PubMed:28240246). By cleaving and activating receptor F2RL1/PAR-2, enhances endothelial cell barrier function and thus vascular integrity during neutrophil transendothelial migration (PubMed:23202369). May play a role in neutrophil transendothelial migration, probably when associated with CD177 (PubMed:22266279). {ECO:0000269|PubMed:2033050, ECO:0000269|PubMed:22266279, ECO:0000269|PubMed:23202369, ECO:0000269|PubMed:28240246, ECO:0000269|PubMed:3198760}.;
Disease
DISEASE: Note=Is the major autoantigen in anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (Wegener's granulomatosis) (PubMed:2377228, PubMed:2679910). This complex, systemic disease is characterized by granulomatous inflammation with necrotizing lesions in the respiratory tract, glomerulonephritis, vasculitis, and anti-neutrophil cytoplasmatic autoantibodies detected in patient sera (PubMed:2377228, PubMed:2679910). PRTN3 causes emphysema when administered by tracheal insufflation to hamsters (PubMed:3198760). {ECO:0000269|PubMed:3198760, ECO:0000303|PubMed:2377228, ECO:0000303|PubMed:2679910}.;
Pathway
Neutrophil degranulation;Other interleukin signaling;Signaling by Interleukins;Cytokine Signaling in Immune system;Antimicrobial peptides;Innate Immune System;Immune System;Hemostasis;Common Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade);C-MYB transcription factor network (Consensus)

Intolerance Scores

loftool
0.378
rvis_EVS
0.46
rvis_percentile_EVS
78.46

Haploinsufficiency Scores

pHI
0.146
hipred
N
hipred_score
0.372
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.591

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Prtn3
Phenotype
hematopoietic system phenotype; immune system phenotype; cellular phenotype;

Gene ontology

Biological process
proteolysis;membrane protein ectodomain proteolysis;phagocytosis;blood coagulation;positive regulation of cell population proliferation;cytokine-mediated signaling pathway;antimicrobial humoral response;collagen catabolic process;neutrophil degranulation;positive regulation of GTPase activity;cell-cell junction maintenance;negative regulation of phagocytosis;neutrophil extravasation;mature conventional dendritic cell differentiation
Cellular component
extracellular region;extracellular space;cytosol;plasma membrane;azurophil granule lumen;plasma membrane raft;collagen-containing extracellular matrix;extracellular exosome
Molecular function
serine-type endopeptidase activity;signaling receptor binding;protein binding;serine-type peptidase activity;enzyme binding